Bank of America’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bank of America’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-20,066	Closed	-$9K	–	7755
2016 Q2	$9K	Buy	20,066 +108	+0.5%	+$173	﹤0.01%	6552
2016 Q1	$54K	Buy	19,958 +2,430	+14%	+$6.82K	﹤0.01%	5758
2015 Q4	$54K	Buy	+17,528	New	+$79K	﹤0.01%	6018
2015 Q3	–	Sell	-83	Closed	–	–	7820
2015 Q2	$0	Hold	83	–	–	﹤0.01%	7725
2015 Q1	$1K	Hold	83	–	–	﹤0.01%	6984
2014 Q4	$0	Hold	83	–	–	﹤0.01%	8473
2014 Q3	$1K	Buy	+83	New	+$717	﹤0.01%	7959

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Bank of America's EPRS Position: Q3 2016 in Review

Bank of America sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 20,066 shares — an estimated $9K sold.

Bank of America first reported a position in EPRS in Q3 2014 and held it in 7 quarters. The position peaked at $54K in Q1 2016. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Bank of America reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Bank of America sold 20,066 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $9K.
Bank of America first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
Bank of America's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $54K in Q1 2016.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.